File

advertisement

Presented By:- The Invincibles

Name Roll No.

Pallavi Baranwal 31A

Pranab Dey 32A

Prashant Mishra 33A

Prerna 34A

Pritam Sadhu 35A

Pushpak Pandey 36A

Nibedita Chakraborty 37A

Ramanand Arora (DL) 38A

Richa Beniwal 39A

Richa Kohli (L) 40A

Introduction

Mr V. C. Burman - Chairman of DIL

Mr Sunil Duggal - CEO of the company.

Dabur India limited is India's leading FMCG company.

Dabur is currently the 4th largest Indian consumer goods manufacturing company (FMCG).

Leading consumer goods company in India with a turnover of Rs. 2,233.72 crores (fy07).

Products of dabur are marketed in more than 50 countries worldwide.

Contd…….

Dabur's health care range brings for the customer a wide selection of herbal products.

Dabur Chyawanprash and Hajmola both gives revenue of Rs.100 crores each.

Dabur Chyawanprash is the leader with 65% share.

Dabur’s digestives category commands 90% of the herbal digestives market.

Hajmola itself is a market leader with 75% market share.

HISTORY(1/4)

1884 BIRTH OF DABUR

1896 SET UP A MANUFACTURING

PLANT

EARLY 1900S AYURVEDIC MEDICINES

1919

1920

ESTABLISHMENT OF

RESEARCH LABORATORIES

EXPANDS FURTHER

1936 DABUR INDIA PVT. LTD.

1972

1979

1986

1992

1994

1995

HISTORY(2/4)

SHIFTS TO DELHI

DABUR RESEARCH

FOUNDATION

PUBLIC LIMITED COMPANY

JOINT VENTURE WITH

AGROLIMEN OF SPAIN

PUBLIC ISSUES

JOINT VENTURES

HISTORY(3/4)

1996 3 SEPARATE DIVISIONS

1997

1998

2000

2003

FOOD DIVISION

PROFESSIONALS TO MANAGE

THE COMPANY

TURNOVER OF RS. 1,000

CRORES

DABUR DEMERGES PHARMA

BUSINESS

2005

2005

2007

2007

2007

HISTORY(4/4)

DABUR ACQUIRES BALSARA

DABUR ANNOUNCES BONUS

AFTER 12 YEARS

CELEBRATING 10 YEARS OF

REAL

FORAY INTO ORGANISED

RETAIL

DABUR FOODS MERGED WITH

DABUR INDIA

MANUFACTURING

 Production facilities to increase in-house production and to get maximum benefits.

 The company believes in cost and quality leadership through technology.

 This has allowed for much greater control on production.

 It is best in class TQM TPM practices.

RESEARCH AND

DEVELOPMENT(1/2)

R&D activities are focused around two basic domains:-

1. To continuously develop new products.

2. To test and guarantee their efficacy.

R&D activities include research on:

1. Ayurvedic and herbal products

2. Organic substances

3. Foods

4. Cosmetics

5. Oral care

6. Personal care

During 2005-06, the company displayed its efficiencies in terms of high “speed to market” by successfully developing its Vatika Honey & Saffron Soap.

RESEARCH AND DEVELOPMENT(2/2)

 The company’s products regularly go through clinical research and toxicity studies which are done in collaboration with Dabur Dhanwantry

Hospital in Chandigarh.

 The company also promotes contract or corporate farming.

 Some example of corporate farming are

Ghorbotch, Brahmi, Chiraita and Pipli.

THE MAIN AREAS OF RESEARCH

 Testing and trial of products.

 Product development for new herbal health and personal care products.

 Development of new chemical entities and formulations.

 New initiatives in Phyto - Pharmaceuticals.

 Developing new products and improvements in foods.

SUPPLY CHAIN

 The supply chain function at dabur comprises of production planning, dispatch, ware housing and transportation.

 Front end of the supply chain ends at the clearing forwarding agent (CFA) or the stockist.

 Project Garuda set up by dabur lays down a set of measurable parameters to test the health of the supply chain.

Dabur India Ltd. : Business Divisions

CONSUMER

CARE

DIVISION

Range of personal care and health care products viz. hair care, oral care, skin care, baby care, health supplements and digestives

CONSUMER

HEALTH

DIVISION

INTERNATIONAL

BUSINESS

DIVISION

FOODS

Range of health care products comprising

Ayurvedic medicines OTC Ayurvedic product

Dabur’s international business based in Dubai ; Having operations in Middle East, Asia, Africa, Australia, UK , US and Canada

Dabur Foods Ltd, a 100% subsidiary comprising

Real Fruit Juices,Hommade cooking pastes & Lemoneez

77%

Business Division

10%

6%

6%

1%

IB DIVISION

CHD

Foods

Misc.

customer care division

CONSUMER

CARE DIVISION

Subsidiaries

Dabur Nepal

Pvt Ltd

Structure

D A B U R I N D I A L I M I T E D

CONSUMER

HEALTH

DIVISION

Dabur

FoodsLtd

Dabur

International

Ltd

MISC.

BUSINESS

Dabur Egypt Ltd

Asian Consumer

Care Pvt Ltd,

Bangla Desh

Weikfield Intl.

(UAE) Llc

Hair Oils

 Hair Oils market estimated by ORG at Rs.14.2 bn.

 Dabur holds 19% share with product offerings in all categories.

 Value added products having herbal USP

 Dabur Amlahair oil –a perfumed hair oil with amla extract , Dabur’s largest brand

 Vatika Hair Oil -Coconut based hair oil with added herbs, one of the fastest growing brands in hair oil market

 Anmol Mustard Amla Hair Oil -newly launched on economy platform

Comparision of Hair oil Producers

Others

37%

HLL

3%

Bajaj

4%

Emami

4%

Keo karpin

6%

Dabur

19%

Marico

27%

HLL

Bajaj

Emami

Keo karpin

Dabur

Marico

Others

SHAMPOOS

Comparision of Shampoo Producers

CLINIC PLUS

25%

VATIKA

6%

LUX

9%

NYLE

3%

AYUR

4%

CHIK

11%

HEAD &

SHOULDERS

7%

PANTENE

7%

CLINIC ALL

SUNSILK

17%

CLEAR

11%

LUX

NYLE

AYUR

CHIK

SUNSILK

CLINIC ALL CLEAR

PANTENE

HEAD & SHOULDERS

CLINIC PLUS

VATIKA

 Shampoo category estimated by ORG at Rs.9 bn.

 Value growth slowing down due to price cuts.

 Dabur Entered Shampoo category in 1997-98, now hold 6% share.

 Dominating the herbal niche in this highly competitive category

 Vatika Henna Cream Conditioning Shampoo.

 Vatika Anti Dandruff Shampoo.

 Anmol Natural Shine Shampoo –launched in current year.

Oral Care

 One of the largest personal care categories estimated at Rs.21 bn.

 Toothpowders account for 20% of the

Category

 Dabur holds 28% share in toothpowder market with Dabur Red Toothpowder

 Launched Dabur Red Toothpaste in 03-04

 An Ayurvedic product

 Captured 1% share of toothpaste market in first year.

TOOTHPASTE

80%

Comparision of Oral Care

TOOTHPOWDER

20%

TOOTHPOWDER

TOOTHPASTE

Health Supplements

 Chyawanprash –largest Ayurvedic medicine with market size of about Rs.2 billion

 Dabur is market leader with 65% share

 Efficacy studies at leading research centers support product effectiveness

 Aggressive marketing inputs being aimed at category expansion

OTHERS

7%

HIMAN

I

ZANDU

11%

Comparision of

Health Suppliments

DABUR

65%

BAIDYANAT

H

12%

DABUR

BAIDYANATH

ZANDU

HIMANI

OTHERS

Digestives

 Dabur holds 29% of the overall digestives market estimated at

Rs.4 billion

 Leader in the herbal digestives category with 90% market share

 Products include

 Hajmola Tablet & Candy

 Pudin Hara (liquid, capsule & effervescent powder)

 Hingoli

 Host of new product introductions in current year under Hajmola brand

Baby Care & Skin Care

 Dabur’s baby care range includes baby oils and tonics

Dabur LalTail – a baby massage oil with Ayurvedic formulation

 Dabur Janma Ghunti -Ayurvedic tonic for infants.

Gripe Water -Digestive tonic for babies.

Dabur Baby Olive Oil -Herb enriched olive oil for massage of infants.

 Dabur’s Skin care range includes

 Dabur Gulabari -Rose Water , a natural astringent and skin toner.

Gulabari Face Pack -blend of sandal and rose in a face pack.

Vatika Fairness Face Pack.

Consumer Health Division

 More than 100 years expertise in herbal Ayurvedic formulations.

 Over 260 medicines for treating a range of ailments and body conditions

 Manufacturing practices follow the Government’s GMP norms

 All Dabur products undergo scientific tests and clinical validation processes

 Tie-ups with Ayurvedic hospitals and colleges for research and promotion of Ayurveda

 Thrust on OTC health care range in future

Major

de com press or are need ed to se e th is p icture.

Categories

Asav

Arishtas

Ras

Rasayanas

Churnas

Medicated

Oils

Proprietary

Ayurvedic

Medicines

GROWTH STRATEGY

EXPAND

DABUR

INDIA

LIMITED

ACQUIRE

INNOVATE

THREE PRONGED STRATEGY FOR SUSTAINING GROWTH

Key Growth Drivers

 Consolidated revenue growth of 16.7% during half year ended 30th September 2008.

 Revenue growth led by price increases to the extent of 4-5%; balance being led by volume.

 The overseas business (IBD) led the growth with an impressive performance of 40.1% for H1FY09.

 Consumer Health Division recorded growth of 22.6%

 Consolidated PAT in core business (excluding retail) grew by

17.8%.

 EBITDA margins in core business maintained at 18.9% in spite of inflationary pressure.

Global Strategy

Developing

Markets

 Expand business in South East Asia,

Middle East and Africa

 Similar consumer preferences and media spillover

 Promote 100% subsidiaries / Joint ventures to overcome tariff barriers barriers

Developed

Markets

 Target Indian diaspora in the first horizon

 Large potential markets for herbal/Ayurvedic Offerings

 Set up distribution alliances for entering mainstream herbal segments

STRENGHTS

1.

STRATEGIC PARTNERSHIPS

2.

WORLD WIDE COVERAGE

3.

100 YEARS OF EXPERIENCE

4.

MANUFACTURING FACILITIES

5.

RESEARCH PLANTS.

WEAKNESS

 No retail outlet.

 No doorstep delivery.

OPPORTUNITY

 Overseas dealership.

 Medical biotechnology.

 Strategic alliances.

 Export of Aurvedic products.

DABUR.COM

 Information is conveyed clearly and in a friendly manner to various constituents from investors to the media.

 The site is well-structured with logical navigation and an amazing amount of information from stock quotes to news.

This shows the brand’s customer-focused attitude.

 There is an abundance of information for its investors and prospective information including a daily update on the share price .

RECOMMENDATIONS

 Diversify its operations.

 Create a Niche Market by integration of

Ayurvedic knowledge with modern science.

 Provide innovative products to its customers.

 Strive for global positioning as Ayurvedic leader.

 Realize its Corporate Social Responsibility.

INTERNATIONAL TIE-UPs…..

Dabur India's health and beauty retail subsidiary H&B stores has tied up with labs in Italy, the UK and Thailand for developing some of its private labels.

 Target:- Rs. 1000 crore revenue.

 Started January this year, the company plans to set up

50 stores by third quarter of 2008-2009.

 Announced the launch of skincare creams and lotions.

 Network of 1.5 million retail outlets in urban and semiurban areas.

THANK YOU

Download